QQ客服 官方微博 反馈留言

	Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets
	Brixner D., Maniadakis N., Kal贸 Z., Hu S., Johnston A., Shen J., Wijaya K.E.
刊名	Value in Health
	2016
卷号	19期号:7
ISSN号	1524-4733
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4641229
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Brixner D., Maniadakis N., Kal贸 Z., Hu S., Johnston A., Shen J., Wijaya K.E.. Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets[J]. Value in Health,2016,19(7).
APA	Brixner D., Maniadakis N., Kal贸 Z., Hu S., Johnston A., Shen J., Wijaya K.E..(2016).Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets.Value in Health,19(7).
MLA	Brixner D., Maniadakis N., Kal贸 Z., Hu S., Johnston A., Shen J., Wijaya K.E.."Application of multi-criteria decision analysis (MCDA) scoring as an HTA methodology for off-patent pharmaceuticals (OPP) in emerging markets".Value in Health 19.7(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。